Medical Research Council updates brain tissue database
The UK Brain Banks Network has been enhanced to include genomic data, which can be accessed by researchers worldwide.
List view / Grid view
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
The UK Brain Banks Network has been enhanced to include genomic data, which can be accessed by researchers worldwide.
A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.
Researchers have mapped a previously uncharted region of the human genome which could lead to tests for certain conditions in the future.
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
A study has used CRISPR-Cas9 to treat obesity and type 2 diabetes symptoms in mice, highlighting the potential use in humans.
Dr Shona Lang investigates the advantages and disadvantages of using organoids within R&D, highlighting the most important questions to ask before using these models.
Researchers have found a molecule, which when deleted, increases leukaemia sensitivity to natural killer cells and is a drug target.
Researchers have created a new technique for activating genes using bacteria which could have therapeutic uses.
AI has applications in many areas of research, including genomics. Slavé Petrovski of AstraZeneca reveals how AI is used in the study of the human genome and how it may evolve in the future.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
Researchers have discovered the mechanism behind the viral genome for measles, which could serve as a druggable target.
A new study has identified possible regulators that determine differences in cancer tumours between genders.
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
Researchers have identified a key process behind senescence, or why cells age, which could be used to improve treatments for cancer.